[HTML][HTML] Adjuvant immunotherapy with autologous cytokine-induced killer cells for hepatocellular carcinoma
Background & Aims No adjuvant therapy has been shown to extend the survival of patients
with hepatocellular carcinoma (HCC) receiving curative treatment. We investigated whether …
with hepatocellular carcinoma (HCC) receiving curative treatment. We investigated whether …
[PDF][PDF] Adjuvant Immunotherapy With Autologous Cytokine-Induced Killer Cells for Hepatocellular Carcinoma
JH Lee, JH Lee - Gastroenterology, 2015 - scholar.archive.org
BACKGROUND & AIMS: No adjuvant therapy has been shown to extend the survival of
patients with hepatocellular carcinoma (HCC) receiving curative treatment. We investigated …
patients with hepatocellular carcinoma (HCC) receiving curative treatment. We investigated …
[PDF][PDF] Adjuvant Immunotherapy With Autologous Cytokine-Induced Killer Cells for Hepatocellular Carcinoma
JH Lee, JH Lee - Gastroenterology, 2015 - pdfs.semanticscholar.org
BACKGROUND & AIMS: No adjuvant therapy has been shown to extend the survival of
patients with hepatocellular carcinoma (HCC) receiving curative treatment. We investigated …
patients with hepatocellular carcinoma (HCC) receiving curative treatment. We investigated …
[PDF][PDF] Adjuvant Immunotherapy With Autologous Cytokine-Induced Killer Cells for Hepatocellular Carcinoma
JH Lee, JH Lee - Gastroenterology, 2015 - researchgate.net
BACKGROUND & AIMS: No adjuvant therapy has been shown to extend the survival of
patients with hepatocellular carcinoma (HCC) receiving curative treatment. We investigated …
patients with hepatocellular carcinoma (HCC) receiving curative treatment. We investigated …
Adjuvant immunotherapy with autologous cytokine-induced killer cells for hepatocellular carcinoma.
JH Lee, YS Lim, JE Yeon, TJ Song, SJ Yu… - …, 2015 - europepmc.org
Methods We performed a multicenter, randomized, open-label, phase 3 trial of the efficacy
and safety of adjuvant immunotherapy with activated CIK cells (created by incubation of …
and safety of adjuvant immunotherapy with activated CIK cells (created by incubation of …
Adjuvant immunotherapy with autologous cytokine-induced killer cells for hepatocellular carcinoma
JH Lee, JH Lee, YS Lim, JE Yeon… - …, 2015 - pubmed.ncbi.nlm.nih.gov
Background & aims No adjuvant therapy has been shown to extend the survival of patients
with hepatocellular carcinoma (HCC) receiving curative treatment. We investigated whether …
with hepatocellular carcinoma (HCC) receiving curative treatment. We investigated whether …
Adjuvant immunotherapy with autologous cytokine-induced killer cells for hepatocellular carcinoma
JH Lee, JH Lee, YS Lim, JE Yeon, TJ Song… - …, 2015 - snucm.elsevierpure.com
Background & Aims No adjuvant therapy has been shown to extend the survival of patients
with hepatocellular carcinoma (HCC) receiving curative treatment. We investigated whether …
with hepatocellular carcinoma (HCC) receiving curative treatment. We investigated whether …
[PDF][PDF] Adjuvant Immunotherapy With Autologous Cytokine-Induced Killer Cells for Hepatocellular Carcinoma
JH Lee, JH Lee - Gastroenterology, 2015 - core.ac.uk
BACKGROUND & AIMS: No adjuvant therapy has been shown to extend the survival of
patients with hepatocellular carcinoma (HCC) receiving curative treatment. We investigated …
patients with hepatocellular carcinoma (HCC) receiving curative treatment. We investigated …
Adjuvant Immunotherapy With Autologous Cytokine-Induced Killer Cells for Hepatocellular Carcinoma
JH Lee, JH Lee, YS Lim, JE Yeon, TJ Song… - …, 2015 - scholar.korea.ac.kr
BACKGROUND & AIMS: No adjuvant therapy has been shown to extend the survival of
patients with hepatocellular carcinoma (HCC) receiving curative treatment. We investigated …
patients with hepatocellular carcinoma (HCC) receiving curative treatment. We investigated …
Adjuvant Immunotherapy With Autologous Cytokine-Induced Killer Cells for Hepatocellular Carcinoma
JH Lee, JH Lee, YS Lim, JE Yeon… - European Journal of …, 2015 - journals.lww.com
Background & Aims: No adjuvant therapy has been shown to extend the survival of patients
with hepatocellular carcinoma (HCC) receiving curative treatment. We investigated whether …
with hepatocellular carcinoma (HCC) receiving curative treatment. We investigated whether …